Colangelo Dominick

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return1%3%< 1%(4%)0%
Purchase Success Rate1 of 21 of 21 of 20 of 20 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 60 of 60 of 60 of 60 of 6

Aastrom Biosciences, Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 220.94K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Oscient Pharmaceuticals Corp.

Drugs » Drug Manufacturers - Major

EVP Corporate Dev & Operations:

Holdings: 46.47K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Trevi Therapeutics, Inc.

Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--